205 related articles for article (PubMed ID: 11234301)
1. [Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically].
Pozzi B; Hotz AM; Feltri M; Cornaggia M; Campiotti L; Bonato M; Pinotti G; Capella C
Pathologica; 2000 Dec; 92(6):503-15. PubMed ID: 11234301
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the proliferative activity as an adjuvant helpful tool in the diagnosis of primary gastric lymphoma in gastrobiopsy.
Gałazka K
Pol J Pathol; 2001; 52(4):205-9. PubMed ID: 11915182
[TBL] [Abstract][Full Text] [Related]
3. A single-center study of treatment outcomes and survival in patients with primary gastric lymphomas between 1990 and 2003.
Jezersek Novaković B; Vovk M; Juznic Setina T
Ann Hematol; 2006 Dec; 85(12):849-56. PubMed ID: 16944146
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic and immunohistochemical study of surgically treated primary gastric MALT lymphoma.
Insabato L; Di Vizio D; Tornillo L; D'Armiento FP; Siciliano A; Milo M; Palmieri G; Pettinato G; Terracciano LM
J Surg Oncol; 2003 Jun; 83(2):106-11. PubMed ID: 12772204
[TBL] [Abstract][Full Text] [Related]
5. Reassessment of gastric lymphoma in light of the concept of mucosa-associated lymphoid tissue lymphoma: analysis of 53 patients.
Hoshida Y; Kusakabe H; Furukawa H; Kasugai T; Miwa H; Ishiguro S; Aozasa K
Cancer; 1997 Sep; 80(6):1151-9. PubMed ID: 9305717
[TBL] [Abstract][Full Text] [Related]
6. bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach.
Omonishi K; Yoshino T; Sakuma I; Kobayashi K; Moriyama M; Akagi T
Mod Pathol; 1998 Feb; 11(2):181-5. PubMed ID: 9504689
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas.
Go JH; Yang WI; Ree HJ
Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
9. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.
Alpen B; Kuse R; Parwaresch R; Müller-Hermelink HK; Stolte M; Neubauer A
J Clin Oncol; 2004 Aug; 22(15):3039-45. PubMed ID: 15284253
[TBL] [Abstract][Full Text] [Related]
10. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
11. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of stomach-conserving therapy in gastric MALT lymphoma.
Vrieling C; de Jong D; Boot H; de Boer JP; Wegman F; Aleman BM
Radiother Oncol; 2008 Jun; 87(3):405-11. PubMed ID: 18343513
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
[TBL] [Abstract][Full Text] [Related]
14. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in primary gastric lymphoma.
Medina-Franco H; Germes SS; Maldonado CL
Ann Surg Oncol; 2007 Aug; 14(8):2239-45. PubMed ID: 17546474
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas.
Dogusoy G; Karayel FA; Göcener S; Göksel S
Pathol Oncol Res; 1999; 5(1):36-40. PubMed ID: 10079376
[TBL] [Abstract][Full Text] [Related]
17. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
Jerkeman M; Anderson H; Dictor M; Kvaløy S; Akerman M; Cavallin-Ståhl E;
Ann Hematol; 2004 Jul; 83(7):414-9. PubMed ID: 15085385
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
19. Gastric MALT lymphoma. A clinico-pathological study of 65 cases. Relationship to Helicobacter pylori.
Ben Rejeb A; Kchir N; Bouali MR; Ebdelli N; Fsili R; Khediri F; Ben Ayedó F; Zitouna MM; Ben Mami N; Kacem M; Filali A; Ben Ammar A
Tunis Med; 2000; 78(8-9):484-93. PubMed ID: 11190724
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
